isis pharmaceuticals and astrazeneca , page-2

so isis picks up $61m in two days from two pharma giants for a bit of exposure to antisense technology.


the space is certainly heating up.

i'm finding the arguments that ANP is overpriced more laughable everyday. peace, i'd be interested in your take on all of this. surely $30m a pop for access to a couple of drugs along with milestones makes $30m a fair value for where ANP is at right now?

if we were a junior energy stock with undeveloped acreage in the eagleford shale, we would be valued on what others were producing.

if we were a U or REE stock during a bubble, we would be valued at whatever crazy price the market felt comfortable with.

i expect this will translate soon enough